Report Detail

Pharma & Healthcare Global Nausea And Vomiting Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • RnM3790333
  • |
  • 30 September, 2019
  • |
  • Global
  • |
  • 100 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Table of Contents

    1 Nausea And Vomiting Treatment Market Overview

    • 1.1 Product Overview and Scope of Nausea And Vomiting Treatment
    • 1.2 Classification of Nausea And Vomiting Treatment by Types
      • 1.2.1 Global Nausea And Vomiting Treatment Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Nausea And Vomiting Treatment Revenue Market Share by Types in 2018
      • 1.2.3 Serotonin Receptor Antagonist
      • 1.2.4 Neurokinin NK1 Receptor Antagonist
      • 1.2.5 Other
    • 1.3 Global Nausea And Vomiting Treatment Market by Application
      • 1.3.1 Global Nausea And Vomiting Treatment Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 CINV
      • 1.3.3 PONV
      • 1.3.4 Motion Sickness
      • 1.3.5 Pregnancy
      • 1.3.6 Others
    • 1.4 Global Nausea And Vomiting Treatment Market by Regions
      • 1.4.1 Global Nausea And Vomiting Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Nausea And Vomiting Treatment Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Nausea And Vomiting Treatment Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Nausea And Vomiting Treatment Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Nausea And Vomiting Treatment Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Nausea And Vomiting Treatment Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Nausea And Vomiting Treatment (2014-2024)

    2 Company Profiles

    • 2.1 Merck & Co. Inc.
      • 2.1.1 Business Overview
      • 2.1.2 Nausea And Vomiting Treatment Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Merck & Co. Inc. Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Taiji group
      • 2.2.1 Business Overview
      • 2.2.2 Nausea And Vomiting Treatment Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Taiji group Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Kyowa Kirin
      • 2.3.1 Business Overview
      • 2.3.2 Nausea And Vomiting Treatment Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Kyowa Kirin Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Helsinn Group
      • 2.4.1 Business Overview
      • 2.4.2 Nausea And Vomiting Treatment Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Helsinn Group Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Teva Pharmaceutical Industries Ltd.
      • 2.5.1 Business Overview
      • 2.5.2 Nausea And Vomiting Treatment Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Unimed Pharmaceuticals (AbbVie Inc.)
      • 2.6.1 Business Overview
      • 2.6.2 Nausea And Vomiting Treatment Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Heron Therapeutics
      • 2.7.1 Business Overview
      • 2.7.2 Nausea And Vomiting Treatment Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Heron Therapeutics Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Qilu Pharma
      • 2.8.1 Business Overview
      • 2.8.2 Nausea And Vomiting Treatment Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Qilu Pharma Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Sanofi
      • 2.9.1 Business Overview
      • 2.9.2 Nausea And Vomiting Treatment Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Sanofi Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Novartis
      • 2.10.1 Business Overview
      • 2.10.2 Nausea And Vomiting Treatment Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Novartis Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Atnahs Pharma UK Limited
      • 2.11.1 Business Overview
      • 2.11.2 Nausea And Vomiting Treatment Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Atnahs Pharma UK Limited Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Tesaro
      • 2.12.1 Business Overview
      • 2.12.2 Nausea And Vomiting Treatment Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Tesaro Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Mylan
      • 2.13.1 Business Overview
      • 2.13.2 Nausea And Vomiting Treatment Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Mylan Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 Duchesnay
      • 2.14.1 Business Overview
      • 2.14.2 Nausea And Vomiting Treatment Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 Duchesnay Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Nausea And Vomiting Treatment Market Competition, by Players

    • 3.1 Global Nausea And Vomiting Treatment Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Nausea And Vomiting Treatment Players Market Share
      • 3.2.2 Top 10 Nausea And Vomiting Treatment Players Market Share
    • 3.3 Market Competition Trend

    4 Global Nausea And Vomiting Treatment Market Size by Regions

    • 4.1 Global Nausea And Vomiting Treatment Revenue and Market Share by Regions
    • 4.2 North America Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
    • 4.5 South America Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)

    5 North America Nausea And Vomiting Treatment Revenue by Countries

    • 5.1 North America Nausea And Vomiting Treatment Revenue by Countries (2014-2019)
    • 5.2 USA Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)

    6 Europe Nausea And Vomiting Treatment Revenue by Countries

    • 6.1 Europe Nausea And Vomiting Treatment Revenue by Countries (2014-2019)
    • 6.2 Germany Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
    • 6.3 UK Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
    • 6.4 France Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Nausea And Vomiting Treatment Revenue by Countries

    • 7.1 Asia-Pacific Nausea And Vomiting Treatment Revenue by Countries (2014-2019)
    • 7.2 China Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
    • 7.5 India Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)

    8 South America Nausea And Vomiting Treatment Revenue by Countries

    • 8.1 South America Nausea And Vomiting Treatment Revenue by Countries (2014-2019)
    • 8.2 Brazil Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Nausea And Vomiting Treatment by Countries

    • 9.1 Middle East and Africa Nausea And Vomiting Treatment Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)

    10 Global Nausea And Vomiting Treatment Market Segment by Type

    • 10.1 Global Nausea And Vomiting Treatment Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Nausea And Vomiting Treatment Market Forecast by Type (2019-2024)
    • 10.3 Serotonin Receptor Antagonist Revenue Growth Rate (2014-2024)
    • 10.4 Neurokinin NK1 Receptor Antagonist Revenue Growth Rate (2014-2024)
    • 10.5 Other Revenue Growth Rate (2014-2024)

    11 Global Nausea And Vomiting Treatment Market Segment by Application

    • 11.1 Global Nausea And Vomiting Treatment Revenue Market Share by Application (2014-2019)
    • 11.2 Nausea And Vomiting Treatment Market Forecast by Application (2019-2024)
    • 11.3 CINV Revenue Growth (2014-2019)
    • 11.4 PONV Revenue Growth (2014-2019)
    • 11.5 Motion Sickness Revenue Growth (2014-2019)
    • 11.6 Pregnancy Revenue Growth (2014-2019)
    • 11.7 Others Revenue Growth (2014-2019)

    12 Global Nausea And Vomiting Treatment Market Size Forecast (2019-2024)

    • 12.1 Global Nausea And Vomiting Treatment Market Size Forecast (2019-2024)
    • 12.2 Global Nausea And Vomiting Treatment Market Forecast by Regions (2019-2024)
    • 12.3 North America Nausea And Vomiting Treatment Revenue Market Forecast (2019-2024)
    • 12.4 Europe Nausea And Vomiting Treatment Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Nausea And Vomiting Treatment Revenue Market Forecast (2019-2024)
    • 12.6 South America Nausea And Vomiting Treatment Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Nausea And Vomiting Treatment Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Description

      Scope of the Report:
      The global Nausea And Vomiting Treatment market is valued at 4435.7 million USD in 2018 and is expected to reach 5646.8 million USD by the end of 2024, growing at a CAGR of 6.2% between 2019 and 2024.
      The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
      North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Nausea And Vomiting Treatment.
      Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
      This report studies the Nausea And Vomiting Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Nausea And Vomiting Treatment market by product type and applications/end industries.

      Market Segment by Companies, this report covers
      Merck & Co. Inc.
      Taiji group
      Kyowa Kirin
      Helsinn Group
      Teva Pharmaceutical Industries Ltd.
      Unimed Pharmaceuticals (AbbVie Inc.)
      Heron Therapeutics
      Qilu Pharma
      Sanofi
      Novartis
      Atnahs Pharma UK Limited
      Tesaro
      Mylan
      Duchesnay

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Serotonin Receptor Antagonist
      Neurokinin NK1 Receptor Antagonist
      Other

      Serotonin Receptor Antagonist had the biggest market share of 61% in 2018.

      Market Segment by Applications, can be divided into
      CINV
      PONV
      Motion Sickness
      Pregnancy
      Others

      CINV is the greatest segment of Nausea And Vomiting Treatment application, with a share of 49% in 2018.


      Summary:
      Get latest Market Research Reports on Nausea And Vomiting Treatment. Industry analysis & Market Report on Nausea And Vomiting Treatment is a syndicated market report, published as Global Nausea And Vomiting Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Nausea And Vomiting Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,713.26
      4,069.89
      5,426.52
      3,155.07
      4,732.60
      6,310.13
      379,748.04
      569,622.06
      759,496.08
      248,413.88
      372,620.83
      496,827.77
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report